Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wheeler

Showing results (951-960 of 1,217) with videos related to

Pageof 122
Sort By:
Diabetes, Obesity & Metabolism|January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney diseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.
Trials|October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trialToby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Journal of the American Society of Nephrology : JASN|May 17, 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-AnalysisAmarnath Marthi, Killian Donovan, Richard Haynes, et al.
Clinical Kidney Journal|February 11, 2022
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysisAlexander D Lalayiannis, Charles J Ferro, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression TrialsRobert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Kidney International|November 13, 2001
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trialH Holdaas, A G Jardine, D C Wheeler, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi PanelSonya Powers, Katherine N Anderson, Wen-Hann Tan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes ManagementPhilip Newland-Jones, Partha Kar, Beth Kelly, et al.
Pageof 122

Showing results (951-960 of 1,217) with videos related to

Sort By:
Pageof 122
Diabetes, Obesity & Metabolism|January 5, 2022
Quételet (body mass) index and effects of dapagliflozin in chronic kidney diseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.
Trials|October 15, 2025
A pragmatic, randomised, open-label, multi-centre UK registry-facilitated trial evaluating the effect of high-dose cholecalciferol on mortality in patients on dialysis: the SIMPLIFIED trialToby J L Humphrey, Fergus J Caskey, David C Wheeler, et al.
Journal of the American Society of Nephrology : JASN|May 17, 2018
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-AnalysisAmarnath Marthi, Killian Donovan, Richard Haynes, et al.
Clinical Kidney Journal|February 11, 2022
The burden of subclinical cardiovascular disease in children and young adults with chronic kidney disease and on dialysisAlexander D Lalayiannis, Charles J Ferro, David C Wheeler, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression TrialsRobert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2016
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)Natalie Staplin, Richard Haynes, William G Herrington, et al.
Kidney International|November 13, 2001
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trialH Holdaas, A G Jardine, D C Wheeler, et al.
Kidney International|February 6, 2018
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceCharles R Swanepoel, Mohamed G Atta, Vivette D D'Agati, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi PanelSonya Powers, Katherine N Anderson, Wen-Hann Tan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2026
Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes ManagementPhilip Newland-Jones, Partha Kar, Beth Kelly, et al.
Pageof 122